1
|
Boyle P and Ferlay J: Cancer incidence and
mortality in Europe, 2004. Ann Oncol. 16:481–488. 2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Kemeny N: Management of liver metastases
from colorectal cancer. Oncology (Williston Park). 20:1161–1176.
1179discussion 1179–1180, 1185–1186. 2006.
|
3
|
Yoo PS, Lopez-Soler RI, Longo WE and Cha
CH: Liver resection for metastatic colorectal cancer in the age of
neoadjuvant chemotherapy and bevacizumab. Clin Colorectal Cancer.
6:202–207. 2006. View Article : Google Scholar : PubMed/NCBI
|
4
|
Chiappa A, Makuuchi M, Lygidakis NJ, Zbar
AP, Chong G, Bertani E, Sitzler PJ, Biffi R, Pace U, Bianchi PP, et
al: The management of colorectal liver metastases: Expanding the
role of hepatic resection in the age of multimodal therapy. Crit
Rev Oncol Hematol. 72:65–75. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Akgül Ö, Çetinkaya E, Ersöz Ş and Tez M:
Role of surgery in colorectal cancer liver metastases. World J
Gastroenterol. 20:6113–6122. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Adam R, Miller R, Pitombo M, Wicherts DA,
de Haas RJ, Bitsakou G and Aloia T: Two-stage hepatectomy approach
for initially unresectable colorectal hepatic metastases. Surg
Oncol Clin N Am. 16:525–536. viii2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Simoneau E, Hassanain M, Shaheen M,
Aljiffry M, Molla N, Chaudhury P, Anil S, Khashper A, Valenti D and
Metrakos P: Portal vein embolization and its effect on tumour
progression for colorectal cancer liver metastases. Br J Surg.
102:1240–1249. 2015. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Lahat E, Eshkenazy R, Zendel A, Zakai BB,
Maor M, Dreznik Y and Ariche A: Complications after percutaneous
ablation of liver tumors: A systematic review. Hepatobiliary Surg
Nutr. 3:317–323. 2014.PubMed/NCBI
|
9
|
Kerkar S, Carlin AM, Sohn RL, Steffes C,
Tyburski J, Littrup P and Weaver D: Long-term follow up and
prognostic factors for cryotherapy of malignant liver tumors.
Surgery. 136:770–779. 2004. View Article : Google Scholar : PubMed/NCBI
|
10
|
Seifert JK, Springer A, Baier P and
Junginger T: Liver resection or cryotherapy for colorectal liver
metastases: A prospective case control study. Int J Colorectal Dis.
20:507–520. 2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
Bilchik AJ, Wood TF, Allegra D, Tsioulias
GJ, Chung M, Rose DM, Ramming KP and Morton DL: Cryosurgical
ablation and radiofrequency ablation for unresectable hepatic
malignant neoplasms: A proposed algorithm. Arch Surg. 135:657–662;
discussion 662–664. 2000. View Article : Google Scholar : PubMed/NCBI
|
12
|
Mulier S, Mulier P, Ni Y, Miao Y, Dupas B,
Marchal G, De Wever I and Michel L: Complications of radiofrequency
coagulation of liver tumours. Br J Surg. 89:1206–1222. 2002.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Curley SA, Marra P, Beaty K, Ellis LM,
Vauthey JN, Abdalla EK, Scaife C, Raut C, Wolff R, Choi H, et al:
Early and late complications after radiofrequency ablation of
malignant liver tumors in 608 patients. Ann Surg. 239:450–458.
2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Elias D, Baton O, Sideris L, Boige V,
Malka D, Liberale G, Pocard M and Lasser P: Hepatectomy plus
intraoperative radiofrequency ablation and chemotherapy to treat
technically unresectable multiple colorectal liver metastases. J
Surg Oncol. 90:36–42. 2005. View Article : Google Scholar : PubMed/NCBI
|
15
|
Elias D, Goharin A, El Otmany A, Taieb J,
Duvillard P, Lasser P and de Baere T: Usefulness of intraoperative
radiofrequency thermoablation of liver tumours associated or not
with hepatectomy. Eur J Surg Oncol. 26:763–769. 2000. View Article : Google Scholar : PubMed/NCBI
|
16
|
Pawlik TM, Izzo F, Cohen DS, Morris JS and
Curley SA: Combined resection and radiofrequency ablation for
advanced hepatic malignancies: Results in 172 patients. Ann Surg
Oncol. 10:1059–1069. 2003. View Article : Google Scholar : PubMed/NCBI
|
17
|
Abdalla EK, Vauthey JN, Ellis LM, Ellis V,
Pollock R, Broglio KR, Hess K and Curley SA: Recurrence and
outcomes following hepatic resection, radiofrequency ablation, and
combined resection/ablation for colorectal liver metastases. Ann
Surg. 239:818–825; discussion 825–827. 2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Kornprat P, Jarnagin WR, DeMatteo RP, Fong
Y, Blumgart LH and D'Angelica M: Role of intraoperative
thermoablation combined with resection in the treatment of hepatic
metastasis from colorectal cancer. Arch Surg. 142:1087–1092. 2007.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Gleisner AL, Choti MA, Assumpcao L, Nathan
H, Schulick RD and Pawlik TM: Colorectal liver metastases:
Recurrence and survival following hepatic resection, radiofrequency
ablation, and combined resection-radiofrequency ablation. Arch
Surg. 143:1204–1212. 2008. View Article : Google Scholar : PubMed/NCBI
|
20
|
Leung EY, Roxburgh CS, Leen E and Horgan
PG: Combined resection and radiofrequency ablation for bilobar
colorectal cancer liver metastases. Hepatogastroenterology.
57:41–46. 2010.PubMed/NCBI
|
21
|
Evrard S, Rivoire M, Arnaud JP, Lermite E,
Bellera C, Fonck M, Becouarn Y, Lalet C, Puildo M and
Mathoulin-Pelissier S: Unresectable colorectal cancer liver
metastases treated by intraoperative radiofrequency ablation with
or without resection. Br J Surg. 99:558–565. 2012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Karanicolas PJ, Jarnagin WR, Gonen M,
Tuorto S, Allen PJ, DeMatteo RP, D'Angelica MI and Fong Y:
Long-term outcomes following tumor ablation for treatment of
bilateral colorectal liver metastases. JAMA Surg. 148:597–601.
2013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Eltawil KM, Boame N, Mimeault R, Shabana
W, Balaa FK, Jonker DJ, Asmis TR and Martel G: Patterns of
recurrence following selective intraoperative radiofrequency
ablation as an adjunct to hepatic resection for colorectal liver
metastases. J Surg Oncol. 110:734–738. 2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Chiappa A, Bertani E, Makuuchi M, Zbar AP,
Contino G, Viale G, Pruneri G, Bellomi M, Della Vigna P, Zampino
MG, et al: Neoadjuvant chemotherapy followed by hepatectomy for
primarily resectable colorectal cancer liver metastases.
Hepatogastroenterology. 56:829–834. 2009.PubMed/NCBI
|
25
|
Couinaud C: Anatomic principles of left
and right regulated hepatectomy: Technics. J Chir (Paris).
70:933–966. 1954.in French.
|
26
|
Martin RC II, Brennan MF and Jaques DP:
Quality of complication reporting in the surgical literature. Ann
Surg. 235:803–813. 2002. View Article : Google Scholar : PubMed/NCBI
|
27
|
Ito K, Govindarajan A, Ito H and Fong Y:
Surgical treatment of hepatic colorectal metastasis: Evolving role
in the setting of improving systemic therapies and ablative
treatments in the 21st century. Cancer J. 16:103–110. 2010.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Singla S, Hochwald SN and Kuvshinoff B:
Evolving ablative therapies for hepatic malignancy. BioMed Res Int.
2014:2301742014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Lee KH, Kim HO, Yoo CH, Son BH, Park YL,
Cho YK, Kim H and Han WK: Comparison of radiofrequency ablation and
resection for hepatic metastasis from colorectal cancer. Korean J
Gastroenterol. 59:218–223. 2012. View Article : Google Scholar : PubMed/NCBI
|
30
|
Tsai S and Pawlik TM: Outcomes of ablation
versus resection for colorectal liver metastases: Are we comparing
apples with oranges? Ann Surg Oncol. 16:2422–2428. 2009. View Article : Google Scholar : PubMed/NCBI
|
31
|
Cirocchi R, Trastulli S, Boselli C,
Montedori A, Cavaliere D, Parisi A, Noya G and Abraha I:
Radiofrequency ablation in the treatment of liver metastases from
colorectal cancer. Cochrane Database Syst Rev. 2012.Article no.
CD006317. View Article : Google Scholar
|
32
|
Benoist S and Nordlinger B: Radiofrequency
ablation in liver tumours. Ann Oncol. 15(Suppl 4): iv313–iv317.
2004.PubMed/NCBI
|
33
|
Ruers T, Punt CJ, van Coeverden F, Borel
Rinkes I, Lederman JA, Poston GJ, Bechstein W, Lentz M, Mauer M,
Nordlinge B, et al: Final results of the EORTC intergroup
randomized study 40004 (CLOCC) evaluating the benefit of
radiofrequency ablation (RFA) combined with chemotherapy for
unresectable colorectal liver metastases (CRC LM). J Clin Oncol.
28(Suppl): 3526A2010.
|
34
|
Nielsen K, van Tilborg AA, Meijerink MR,
Macintosh MO, Zonderhuis BM, de Lange ES, Comans EF, Meijer S and
van den Tol MP: Incidence and treatment of local site recurrences
following RFA of colorectal liver metastases. World J Surg.
37:1340–1347. 2013. View Article : Google Scholar : PubMed/NCBI
|
35
|
Machi J, Uchida S, Sumida K, Limm WM,
Hundahl SA, Oishi AJ, Furumoto NL and Oishi RH: Ultrasound-guided
radiofrequency thermal ablation of liver tumors: Percutaneous,
laparoscopic, and open surgical approaches. J Gastrointest Surg.
5:477–489. 2001. View Article : Google Scholar
|
36
|
Ahmad A, Chen SL, Kavanagh MA, Allegra DP
and Bilchik AJ: Radiofrequency ablation of hepatic metastases from
colorectal cancer: Are newer generation probes better? Am Surg.
72:875–879. 2006.PubMed/NCBI
|
37
|
Eisele RM, Neumann U, Neuhaus P and
Schumacher G: Open surgical is superior to percutaneous access for
radiofrequency ablation of hepatic metastases. World J Surg.
33:804–811. 2009. View Article : Google Scholar : PubMed/NCBI
|
38
|
Pearson AS, Izzo F, Fleming RYD, Ellis LM,
Delrio P, Roh MS, Granchi J and Curley SA: Intraoperative
radiofrequency ablation or cryoablation for hepatic malignancies.
Am J Surg. 178:592–599. 1999. View Article : Google Scholar
|
39
|
Stoltz A, Gagnière J, Dupré A and Rivoire
M: Radiofrequency ablation for colorectal liver metastases. J Visc
Surg. 151(Suppl 1): S33–S44. 2014. View Article : Google Scholar : PubMed/NCBI
|
40
|
Pillai K, Akhter J, Chua TC, Shehata M,
Alzahrani N, Al-Alem I and Morris DL: Heat sink effect on tumor
ablation characteristics as observed in monopolar radiofrequency,
bipolar radiofrequency, and microwave, using ex vivo calf liver
model. Medicine (Baltimore). 94:e5802015. View Article : Google Scholar
|
41
|
Mulier S, Ni Y, Jamart J, Ruers T, Marchal
G and Michel L: Local recurrence after hepatic radiofrequency
coagulation: Multivariate meta-analysis and review of contributing
factors. Ann Surg. 242:158–171. 2005. View Article : Google Scholar : PubMed/NCBI
|
42
|
Dwerryhouse SJ, Seifert JK, McCall JL,
Iqbal J, Ross WB and Morris DL: Hepatic resection with cryotherapy
to involved or inadequate resection margin (edge freeze) for
metastases from colorectal cancer. Br J Surg. 85:185–187. 1998.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Nikfarjam M, Muralidharan V,
Malcontenti-Wilson C, McLaren W and Christophi C: Impact of blood
flow occlusion on liver necrosis following thermal ablation. ANZ J
Surg. 76:84–91. 2006. View Article : Google Scholar : PubMed/NCBI
|
44
|
Curley SA: Radiofrequency ablation versus
resection for resectable colorectal liver metastases: Time for a
randomized trial? Ann Surg Oncol. 15:11–13. 2008. View Article : Google Scholar :
|
45
|
Rubin DB: Estimating causal effects from
large data sets using propensity scores. Ann Intern Med.
127:757–763. 1997. View Article : Google Scholar
|